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ABSTRACT 
Objectives: To investigate antidepressant use, including the class of antidepressant, in mid-
age and older Australians according to sociodemographic, lifestyle and physical and mental 
health-related factors. 
Methods: Baseline questionnaire data on 111,705 concession-card holders aged ≥45 years 
from the 45 and Up Study—a population-based cohort study from New South Wales, 
Australia—were linked to administrative pharmaceutical data. Current- and any-
antidepressant users were those dispensed medications with Anatomical Therapeutic 
Chemical classification codes beginning N06A, within ≤6 months and ≤19 months before 
baseline, respectively; non-users had no antidepressants dispensed ≤19 months before 
baseline. Multinomial logistic regression was used to calculate adjusted relative risk ratios 
(aRRRs) for predominantly self-reported factors in relation to antidepressant use. 
Results: Nineteen percent of the study population (15% of males and 23% of females) were 
dispensed at least one antidepressant during the study period. Forty percent of participants 
used selective-serotonin reuptake inhibitors (SSRIs) only and 32% used tricyclic 
antidepressants (TCAs) only. Current antidepressant use was markedly higher in those 
reporting: severe versus no physical impairment (aRRR 3.86(95%CI 3.67-4.06)); fair/poor 
versus excellent/very good self-rated health (4.04(3.83-4.25)); high/very high versus low 
psychological distress (7.22(6.81-7.66)); ever- versus never-diagnosis of depression by a 
doctor (18.85(17.95-19.79)); low dose antipsychotic use versus no antipsychotic use 
(12.26(9.85-15.27)); and dispensing of ≥10 versus <5 other medications (5.97(5.62-6.34)). 
Sociodemographic and lifestyle factors were also associated with use, although to a lesser 
extent. Females, older people, those with lower education and those with poorer health were 
more likely to be current antidepressant users than non-users and were also more likely to use 
TCAs-only versus SSRIs-only. 
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Conclusions: Use of antidepressants is substantially higher in those with physical ill-health 
and in those reporting a range of adverse mental health measures. In addition, 
sociodemographic factors, including sex, age and education were also associated with 
antidepressant use and the class of antidepressant used. 
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INTRODUCTION  
Antidepressant medications are among the most highly prescribed medications in Australia 
and use has been increasing over time. In 2011, 89 defined daily doses (DDD) (WHO 
Collaborating Centre for Drug Statistics Methodology, 2012) of antidepressants were 
dispensed per 1,000 people per day (1000/day) in Australia, up from approximately 45 
DDD/1000/day in 2000 (Organisation for Economic Co-operation and Development, 2013). 
Compared to other OECD countries, Australia had the second highest use of antidepressants 
in 2011, behind Iceland (Organisation for Economic Co-operation and Development, 2013). 
Evidence regarding the patterns of use of antidepressants in Australia, and the characteristics 
of users, is limited. Such evidence is important for informing a range of areas, including the 
quality use of medications, the cost implications of use and in understanding the likely impact 
of use on population health.  
 
International studies have shown that health-related factors such as depressive symptoms, 
physical functioning impairment and number of medications used are strongly related to 
antidepressant use (Karkare et al., 2011; Blazer et al., 2005; Ganguli et al., 1997; Grunebaum 
et al., 2008; Pfeiffer et al., 2011). Social determinants—including age, sex, socioeconomic 
status, ethnicity and region of residence—that may predispose people to use antidepressants 
or affect a person’s ability to access them (Andersen and Newman, 2005), have also been 
linked to antidepressant use (Brown et al., 1995; Ganguli et al., 1997; Grunebaum et al., 
2008; Pfeiffer et al., 2011). Differences in health care systems between countries mean the 
profile of antidepressant users, particularly in relation to socioeconomic factors, is likely to 
differ across populations. Most studies to date have used data from United States (US) 
populations and, given the differences between the Australian and US health care systems 
(Schoen et al., 2004), it is important examine this issue using Australian data.  To date, few 
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Australian studies have been undertaken that examine individual-level factors associated with 
antidepressant use in non-institutional populations (Goldney et al., 2007; Page et al., 2009; 
Zhang et al., 2010) and most have been limited to using aggregated data. Further, we are not 
aware of any previous studies, Australian or international, that have examined whether health 
indicators and behaviours such as body mass index, physical activity, alcohol consumption 
and cigarette smoking, are associated with antidepressant medication use. 
 
There is limited evidence suggesting that the characteristics of people using antidepressants 
may also vary by antidepressant class. A US study published in 1998 reported that men, those 
of African-American race and older people were more likely to use tricyclic antidepressants 
(TCA) than newer generation selective serotonin reuptake inhibitors (SSRI) (Sclar et al., 
1998). However, little is known about what other factors may be associated with the class of 
antidepressant used or whether sociodemographic variations occur in Australia. 
 
This study contributes to existing knowledge by linking detailed survey data to recorded 
dispensings of medication use to investigate the relative distributions of antidepressant use in 
mid-age and older Australians according to sociodemographic, lifestyle and physical and 
mental health-related factors. Secondarily, it examines whether the factors associated with 
antidepressant use vary according to the class of antidepressant used. 
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METHODS 
Data sources and study population 
We undertook analyses using data from the 45 and Up Study baseline questionnaire linked to 
dispensing information from Pharmaceutical Benefits Scheme (PBS) records.  
 
The 45 and Up Study is an Australian cohort involving 267,153 men and women aged 45 
years or over from New South Wales (NSW), Australia. Participants in the Study were 
randomly sampled from the database of Medicare Australia, which provides virtually 
complete coverage of the general population. Approximately 10% of the NSW population 
aged 45 years or older was included. Participants joined the Study by completing a baseline 
questionnaire—distributed from January 2006 to December 2008—and giving signed consent 
for follow-up and linkage of their information to a range of health databases including the 
PBS database. The Study is described in detail elsewhere (Banks et al., 2008) and 
questionnaires can be viewed at http://www.45andup.org.au.  
 
The PBS is an administrative dataset containing information about dispensed prescription 
medications. The PBS allows Australian residents access to a large range of medications at 
subsidised costs (Department of Health and Ageing, 2013). People contribute a co-payment 
toward the cost of their medication and the remaining cost is covered under the PBS.  Aged 
pensioners and other social security recipients pay a ‘concessional’ co-payment (this ranged 
over the study period from AU$3.80 in 2004 to AU$5.30 in 2009), which is lower than the 
‘general’ population co-payment (AU$23.70 in 2004, AU$32.90 in 2009). The PBS dataset 
did not capture below co-payment dispensings to general beneficiaries before 2012 and thus 
this study was restricted to 45 and Up Study participants who were concessional beneficiaries 
(those with at least one concessional and no non-concessional claim) during the study period. 
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Selection of PBS records and participants for inclusion in this study 
PBS records from 2004-2011 were available for 45 and Up study participants. The study 
period was defined for each participant as the 19 months before completion of the baseline 
questionnaire. Participants who self-reported holding a Department of Veterans' Affairs card 
were excluded, as these people have access to a broader range of subsided medications under 
a separate Government program.  
 
The Sax Institute linked the baseline 45 and Up questionnaire data and the PBS data. The 
PBS data were supplied by the Department of Human Services.  
 
Measurements 
Outcomes   
Dispensing of antidepressant medications were identified from the PBS dataset as those with 
Anatomical Therapeutic Chemical (ATC) classification codes beginning with N06A (World 
Health Organization Collaborating Centre for Drug Statistics Methodology, 2013). 
Consecutive dispensings were defined as at least two dispensings, where the time between the 
dispensings was less than or equal to the maximum standard supply period (based on the pack 
size, e.g. if pack size is 30 tablets, the maximum standard supply period is 30 days) plus a 
refill period of eight days. 
 
Participants were classified according to whether or not they had received any dispensing for 
an antidepressant during the study period. Study participants who received a dispensing of an 
antidepressant were further categorised as: current users; past-only users; and non-persistent 
users. As PBS data only provide information about dispensing, not actual use of the 
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medications, we defined current and past-only users as those with two or more consecutive 
dispensings of an antidepressant (Eaddy et al., 2005; Andrade et al., 2006). Current users 
were defined as those who had at least two consecutive dispensings of an antidepressant 
medication within the six month period before completion of the baseline questionnaire 
(regardless of past use). Past-only users were defined as participants who had at least two 
consecutive dispensings of any antidepressant medication within the 19-month study period 
but no consecutive dispensings of two or more antidepressant medications within the six 
months before completion of the baseline questionnaire. Non-persistent users were defined 
as participants who had at least one dispensing or one or more non-consecutive dispensings 
of any antidepressant within the study period.  Non-users were defined as those who were not 
dispensed any antidepressant medication within the study period. 
 
Current antidepressant users were further classified by the class of antidepressant dispensed 
during the study period including: selective-serotonin reuptake inhibitor (SSRI)-only use 
(ATC codes N06AB02-N06AB10); tricyclic antidepressant (TCA)-only use (ATC codes 
N06AA01 - N06AA23); other antidepressant use(single type) (including monoamine oxidase 
inhibitors (MAOI) and serotonin-noradrenaline reuptake inhibitors (SNRI)) (ATC codes 
N06AF01- N06AF06, N06AG02- N06AG03 and N06AX01- N06AX26); and combination 
use (more than one antidepressant class dispensed). 
 
Exposures 
Consistent with the Anderson-Newman model of healthcare utilisation (Andersen and 
Newman, 1973), a number of pre-disposing, enabling and need-related factors were examined 
as exposures. All exposures—except for region of residence, dispensing of antipsychotics and 
number of medications dispensed—were derived from self-reported baseline questionnaire 
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responses. Region of residence was derived from the postcode obtained from Medicare data, 
and dispensing of antipsychotics and number of medications dispensed were derived from 
PBS data. 
 
Pre-disposing factors were considered to be those that influence a person’s likelihood of 
using health care and medications (Andersen and Newman, 2005).  These included: age; sex; 
marital status (categorised as married/de-facto or not married/de-facto); country of birth 
(categorised as Australia/New Zealand, Europe/North America or other); education (based on 
highest completed qualification and categorised as no school certificate, school certificate, 
apprenticeship/trade/certificate/diploma or university degree or higher); body mass index 
(BMI) (calculated as self-report weight in kilograms divided by height in metres squared and 
categorised as underweight (15-<18.5kg/m
2
);  normal weight (18.5-<25kg/m
2
); overweight 
(25-<30kg/m
2
); and obese (30-50kg/m
2
)); physical activity tertile (based on the weighted 
number of reported weekly sessions of walking, moderate activity and vigorous activity 
(Australian Institute of Health and Welfare, 2003) and categorised as low, medium or high); 
smoking status (never, past, current); and alcohol consumption (drinks per week categorised 
as none, light (1-10 drinks for men and 1-5 drinks for women), moderate (11-35 drinks for 
men and 6-20 drinks for women) and heavy (>35 drinks for men and >20 drinks for women) 
(Power et al., 1998)). 
 
Enabling factors are those that allow an individual to access health care and medications if 
they need or choose to (Andersen and Newman, 2005) and these included: pre-tax household 
income (categorised as <$20,000, $20,000-$39,999, $40,000-$69,999 or ≥$70,000 AUD); 
private health insurance (yes/no); and region of residence (based on the 
Accessibility/Remoteness Index of Australia Plus (Australian Institute of Health and Welfare, 
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2004) score associated with the postcode of residence and categorised as major cities, inner 
regional or more remote). 
 
Need-related factors included general indicators for health as well as factors measuring 
depression and other mental illness – these are factors that result in a person needing (or 
perceiving the need) to access health care and medications (Andersen and Newman, 2005). 
General indicators for health included: physical impairment (derived from the Medical 
Outcomes Score-Physical Functioning (MOS-PF), which is equivalent to items from the 
physical functioning scale of the SF-36 health survey (Stewart and Ware, 1992) and 
categorised as none/minor (score of 100-75), moderate (50-74), or severe (<50)); self-rated 
health (categorised as excellent/very good, good or fair/poor); and number of other 
medications dispensed (based on total number of unique medications other than 
antidepressants dispensed during the study period, categorised as <5, 5-9, or ≥10). Proxy 
measures of depression and mental illness included: psychological distress (based on 
responses to the Kessler 10 scale (Kessler et al., 2002) and categorised as low (score of <16), 
moderate (16-<22), or high/very high (≥22)); ever doctor-diagnosed depression (yes/no); and 
current treatment for depression or anxiety (yes/no). The questions asked in the Study 
questionnaire have changed over time and up until a certain time the question about whether 
participants had ever been diagnosed with depression by a doctor was not included in the 
questionnaire; thus responses for this variable were missing for approximately 14% of 
participants. Antipsychotics are  prescribed for managing psychosis which can occur in a 
number of different mental illnesses, most commonly in schizophrenia and bipolar disorder 
(Maher and Theodore, 2012), but also major depression (Papakostas et al., 2007). As such, 
we included antipsychotic use as a need-related exposure in this study. Antipsychotic use was 
ascertained by any dispensing of an item with ATC code beginning with N05A during the 
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study period and was categorised as low, medium, high and combination doses based on the 
drug strength dispensed. 
 
Statistical methods 
The proportion of participants, by sex and age, dispensed at least one antidepressant during 
the study period was calculated. The proportion of participants in each antidepressant user 
category was then calculated in relation to the exposures, and differences between groups 
were compared using chi squared tests. We then used multinomial logistic regression to 
model the relationships between the exposure variables and antidepressant use.  
 
Separate multinomial logistic regression models were used to: i) estimate the strength of the 
relationship between each exposure and antidepressant user categories (reference: non-users); 
and ii) estimate the strength of the relationship between each exposure and the class of 
antidepressant used for current antidepressant users only (reference: SSRI-only use). All 
models were adjusted for the non-modifiable factors: sex, age and country of birth.  
 
The primary focus of this study was to compare current users to non-users. While we also 
examined factors associated with past-only and non-persistent users, the results for these are 
given in a supplementary table, and the results and discussion of this paper focus on current 
users. 
 
The strength of association estimates generated from the multinomial logistic regressions are 
reported as relative risk ratios (RRR), which express the relative risk of having the outcome 
compared to not having the outcome in relation to different levels of the exposure variables 
(StataCorp, 2011). For example, a RRR of 1.5 for females currently using antidepressants can 
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be interpreted as: for females compared to males, the relative risk of being a current 
antidepressant user compared to a non-user is 1.5. In all analyses, 95% confidence intervals 
were generated. All analyses were performed using Stata version 12.0 and were undertaken 
using the Secure Unified Research Environment (Sax Institute, 2014). Ethics approval for this 
project was obtained from the NSW Population and Health Services Research Ethics 
Committee and the Australian National University Human Research Ethics Committee. 
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RESULTS 
After excluding participants with no concessional-only PBS records during the study period 
(n=152,555) and those with a Departments of Veterans' Affairs card (n=5), a total of 111,705 
participants remained in the study. Summary characteristics of the study population by 
antidepressant user category are presented in Table 1 and Figure 1. Nineteen percent (21,750) 
of the participants had been dispensed at least one antidepressant medication (total 
dispensings=260,134) during the study period. Approximately 15% of males and 23% of 
females were dispensed an antidepressant with the proportion of users decreasing with age 
from 30% in those aged 45-54 years to 18% in those aged 85 years or older.  The pattern of 
antidepressant use by age was similar for both men and women (Figure 1). The proportion of 
people using antidepressants decreased with increasing level of education, income and self-
rated health, and increased with increasing level of physical functioning impairment, 
psychological distress and the number of other medications dispensed during the study period 
(Table 1). 
 
Of the participants who reported at baseline that they were currently being treated for 
depression or anxiety, 58% were current antidepressant users, as were 6% of people who 
reported not being currently treated for depression or anxiety.  Conversely, of those who were 
current antidepressant users, 53% reported that they were being currently treated for 
depression or anxiety, while 47% of current users reported not being currently treated for 
depression or anxiety. 
  
Of those dispensed any antidepressant during the study period, 40% were dispensed an SSRI 
only, 32% were dispensed a TCA only, and 17% used another type of antidepressant 
(including MAOI and SNRIs). The remaining 11% were dispensed more than one class of 
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antidepressant (combination use) (Table 2). The proportion of people using the different 
antidepressant classes was similar across current, past-only and non-persistent users, except 
that the proportion of people dispensed a TCA was higher for non-persistent users than 
current and past-only users. 
 
Predisposing factors related to current antidepressant use 
After adjusting for sex, age and country of birth, all predisposing factors were statistically 
associated with current antidepressant use (Figure 2 and Supplementary Table 1). Females, 
younger participants (45-54 years), those born in Australia or New Zealand, those not in a 
married or de-facto relationship and those with lower levels of education were more likely to 
use antidepressants than their counterparts. Those who were underweight, overweight or 
obese were more likely to use antidepressants than those with a normal BMI. People who 
were less physically active (compared to those in the highest physical activity tertile) and 
those who were past or current smokers (compared to never smokers) were also more likely 
to use antidepressants. Compared to those consuming a moderate amount of alcohol, those 
who did not drink alcohol and heavy drinkers were more likely to be current antidepressant 
users.  
 
Enabling factors related to current antidepressant use 
Of the enabling factors, income and private health insurance were associated with current 
antidepressant use, after adjusting for sex, age and country of birth (Figure 3). Compared to 
people with an annual household income of $70,000 or more, those with a lower income were 
more likely to be current antidepressant users [RRR ranging from 1.67 (95% CI:1.34-2.08) 
for those with an income of $40,000-$69,999 to 3.51 (2.85-4.32) for those with an income of 
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<$20,000]. People with private health insurance, compared to no private health insurance, 
were less likely to be current antidepressant users [RRR=0.76 (0.73-0.79)].  
 
Need-related factors related to current antidepressant use 
All need-related factors were strongly associated with current antidepressant use, after 
adjustment for sex, age and country of birth (Figure 4). People with physical impairment 
(compared to no/minor impairment), more dispensed medications (compared to <5) and 
poorer self-rated health (compared to excellent/very good health) were more likely to be 
current antidepressant users. Factors measuring mental health showed the strongest statistical 
association with current antidepressant use. Compared to people with low psychological 
distress, those with moderate and high/very high psychological distress were 3.16 (3.00-3.34) 
and 7.22 (6.81-7.66) times as likely to be current antidepressant users than non-users, while 
those who reported ever being diagnosed with depression by a doctor were 18.85 (17.95-
19.79) times as likely to be a current antidepressant users than non-users, compared to those 
who hadn’t been diagnosed with depression by a doctor. Similarly, those dispensed any 
antipsychotic during the study period (not necessarily at the same time as antidepressant 
dispensings) were more likely to be current antidepressant users than those not dispensed any 
antipsychotics [RRR ranging from 6.05 (4.50-8.13) for those using high dose antipsychotics 
to 12.26 (9.85-15.27) for those using low dose antipsychotics]. 
 
After adjustment for sex, age and country of birth, the exposures associated with past-only 
use and non-persistent use were the same as those associated with current antidepressant use 
(Supplementary table 1). 
 
Factors associated with use of different antidepressant classes  
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Table 3 shows the association between different factors and classes of antidepressant 
dispensed, among people who were current antidepressant users. Of the predisposing 
factors—after adjustment for sex, age and country of birth—females, older people (compared 
to those aged 45-54 years) and those with a lower education (compared to a university degree 
or above) were statistically more likely to use a TCA-only than a SSRI-only. Additionally, 
compared to using a SSRI-only, people born in a country other than Australia or New 
Zealand, those not married or in a de-facto relationship and those with a lower education 
(compared to a university degree or above) were more likely to use a combination of 
antidepressant classes, while older people (compared to those aged 45-54 years) were less 
likely to be use a combination of antidepressant classes. 
 
Of the need-related factors, those with poorer health (good or fair/poor self-rated health; ≥5 
medications dispensed; and moderate or severe physical impairment) were generally 
statistically more likely to use a TCA-only, other type of antidepressant (single type) or a 
combination of antidepressant classes compared to using a SSRI-only. In contrast, people 
with poor mental health (moderate or high/very high psychological distress; having ever been 
diagnosed with depression by a doctor; and antipsychotic use) were less likely to use a TCA-
only compared to a SSRI-only (although this was not statistically significant for use of 
antipsychotics), but were also more likely to use a other type of antidepressant (single type) 
or a combination of antidepressant classes compared to a SSRI-only.  
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DISCUSSION 
Principal findings  
Factors related to an individuals’ general physical and mental well-being, i.e. need-related 
health factors and, to a lesser degree, some predisposing and enabling factors, are associated 
with current antidepressant use in our sample of Australian adults. Our findings show that 
people with poorer physical and mental health (as indicated by moderate-severe physical 
impairment; fair-poor self-rated health; moderate-very high psychological distress; ever 
diagnosis of depression by a doctor; antipsychotic use; and polypharmacy) were most likely 
to be current antidepressant users, as were females, younger people, those born in 
Australia/New Zealand, those with low levels of physical activity and those with a lower 
income. Sex, age, education and physical and mental health factors were also associated with 
the use different classes of antidepressants (TCA-only, single types of other antidepressants 
only, or a combination of antidepressants) compared to use of the more common SSRI-only.  
 
Results of the study in relation to other studies 
Our results are consistent with those of previous international and Australian studies which 
have shown that being female and having poorer physical and mental health is strongly 
associated with antidepressant use (Blazer et al., 2005; Ganguli et al., 1997; Grunebaum et 
al., 2008; Harris et al., 2011; Karkare et al., 2011; Pfeiffer et al., 2011; Zhang et al., 2010; 
Brown et al., 1995). Specifically, these studies have provided evidence that those with: poor 
self-rated health, more doctor visits; polypharmacy; high psychological distress; depressive 
or anxiety symptoms; cognitive impairment; physical functioning impairment; and one or 
more chronic conditions, are more likely to use antidepressants than their counterparts. Our 
studies confirm these findings, and further add to the literature by showing antipsychotic 
use—which is prescribed for managing psychosis and may be prescribed for those with 
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diagnosed depression—and other health-related indicators and behaviours, including BMI, 
physical activity, smoking status and alcohol consumption are also associated with current 
use of antidepressants.  
 
In contrast to other studies, while we found that people with lower levels of education and 
lower income were more likely to be antidepressant users, previous studies have shown the 
opposite or no association between these two factors and antidepressant use. A large study 
conducted in Finland (n=65,405) found that, in men, those with a primary or secondary 
education compared to a tertiary education were statistically less likely to use antidepressants, 
while no statistical association was seen for women (Kivimaki et al., 2007). Other studies 
(from the US) reported no statistical association between education and antidepressant use 
(Blazer et al., 2000; Grunebaum et al., 2008). Similarly, most previous studies that have 
investigated the association between income and antidepressant association have found no 
significant relationship (Blazer et al., 2000; Grunebaum et al., 2008; Soudry et al., 2008), 
with the results of another study suggesting that people with higher levels of income were 
more likely to use antidepressants (Brown et al., 1995). A possible reason for discrepancy 
between our results and those from other countries is that, because the concessional PBS 
benefits are available to low-income earners, access to medications in this subset of the 
Australian population may not be as tied to the ability to pay as in other countries. Instead, 
the association between higher antidepressant use and lower income observed in our study 
may reflect the increased burden of mental illness within this group of people. This is 
supported by a previous study using data from the 45 and Up Study, which showed an 
association between low income and low education and increased odds of high psychological 
distress (Banks et al., 2010). Furthermore, the observed association between low income and 
increased likelihood of antidepressant use in our study may reflect the lower cost of 
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antidepressants and their widespread availability compared to psychotherapy. Indeed, we 
found that over half (58%) the people who reported at baseline that they were currently being 
treated for depression or anxiety were current antidepressant users. This suggests the other 
42% of people may be accessing another form of treatment, such as psychotherapy. 
 
With regard to the relationship between individual-level factors and the type of antidepressant 
class used, we found that women and older people were more likely than men and younger 
people to use a TCA-only compared to a SSRI-only. This is in contrast to the findings of a 
US study which showed that men rather than women were more likely to use a TCA than a 
SSRI, although they did similarly find that older people were more likely to use a TCA than 
an SSRI (Sclar et al., 1998). It is not clear why our study results were different to the US 
study in terms of the relationship between sex and antidepressant class, however, the US 
study used data from 1990-1994 so differences in time and setting may reflect a difference in 
patterns of prescribing. A further possible explanation is that SSRIs and TCAs may be 
prescribed for different indications, so the differences between the studies may reflect 
differences in the prevalence of conditions being prescribed for. For example, a previous 
Australian study found that SSRIs were used only for mental illness while TCAs were used 
for physical conditions (pain, migraine and urinary incontinence) as well as mental illness 
(Zhang et al., 2010). It is also possible that TCAs are prescribed secondarily to people who 
did not respond to SSRIs, so the results may reflect a difference in the proportion of people 
with more severe depression.  
 
Our finding that not all antidepressant users report being currently treated for depression or 
anxiety supports the findings from a previous Australian study (Hollingworth et al., 2010). 
This study used Australian data from the 2007 National Survey of Mental Health and 
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Wellbeing and PBS data (2002-07), finding that the prevalence of self-reported affective and 
anxiety disorders (including depression) were highest in those aged less than 50 years while 
antidepressant use was highest in those aged 90 to 94 years old (Hollingworth et al., 2010). 
Although these findings could be explained by inaccurate self-reporting of mental illness, a 
further Australian study of men and women living in the community or in residential care 
examined the reasons for antidepressant use, finding that 70% of use was for psychological 
reasons and 10% were reported for physical reasons (Zhang et al., 2010). While we were 
unable to explore the reasons for antidepressant use explicitly using our data, taken together, 
these results suggest that some people may be using antidepressants for both mental and 
physical health reasons. However, our finding may have been due to the six month “window” 
that we considered current use, such that individuals may not have been taking the 
medication at the time of completing the questionnaire. It may also indicate that a proportion 
of people who are using antidepressants may not consider themselves to have a diagnosis of 
depression for some other reason.  
 
Strengths and weakness of this study 
The main strengths of this study are its: large sample size; population-based nature; linkage 
of detailed questionnaire data to detailed independent administrative information on 
medication dispensing; and information on a variety of diverse exposures. There are three 
main limitations of this study. First, information on most exposures (with the exception of 
region of residence, use of antipsychotics and number of medications dispensed) was self-
reported. While this is likely to be accurate for many exposures such as age, sex, education 
and country of birth, other factors such as weight, height, physical activity and alcohol 
consumption may be less accurately reported. However, this potential bias is likely to be non-
differential as the accuracy of the self-report is unlikely to vary by whether or not a person 
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was using an antidepressant; this would likely bias the results towards the null (no effect). 
Second, the PBS data do not provide information on actual use (only individual dispensings 
of medication). To deal with this we defined the main outcome of current antidepressant use 
as those with two or more consecutive dispensings rather than any dispensing of an 
antidepressant. Third, this study was restricted to only those within the 45 and Up Study who 
had concessional PBS dispensings during the study period. This sample is likely to be older, 
sicker and poorer than the general population and thus is not representative of all those using 
antidepressants in the Australian population.  We found that 19% of our study population had 
been dispensed at least one antidepressant during the 19-month study period. While not 
directly comparable, this is higher than the prevalence reported in representative Australian 
surveys such as the 2004-05 National Health Survey in which 5% of people reported having 
used an antidepressant for mental wellbeing in the two-week period before the survey 
(Australian Bureau of Statistics, 2006). While the absolute results, particularly the proportion 
of antidepressant users estimated in this study, should be regarded with caution, it has been 
previously shown that the relative measures of association calculated in non-representative 
cohort studies can be generalized to the broader population (Mealing et al., 2010).  
 
The aim of this study was not to examine causal exposures of antidepressant use, but to 
instead examine how the distribution of antidepressant use varies by sociodemographic, 
lifestyle and health characteristics. Further, the PBS data do not provide information on the 
indication for which the medication is prescribed and thus, antidepressant use as described in 
this study should not be used as a proxy of the prevalence of depression.  
 
What does this study mean? 
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Our results indicate that people with poorer physical and mental health are more likely to use 
antidepressants than their healthier counterparts. We also found a relationship between 
sociodemographic and lifestyle factors and antidepressant use, however, the analyses were 
only adjusted for sex, age and country of birth, and thus at least some of this relationship is 
likely to reflect underlying differences in health. Indeed, the results observed in this study 
appear to broadly reflect underlying distributions of mental illness in Australia. Results from 
the 2007 National Survey of Mental Health and Wellbeing showed that more women (22%) 
than men (18%) reported having a mental disorder in the 12 months before the survey and the 
prevalence of mental illness decreased with age (Australian Bureau of Statistics, 2013). 
Further, the prevalence of mental illness increased with decreasing labour force participation 
(which is strongly related to morbidity, education and income) and was higher in current 
smokers (compared to never smokers) and in those with severe disability (compared to no 
disability) (Australian Bureau of Statistics, 2008). This profile of mental disorder in the 
Australian population is similar to that observed for antidepressant users in this study. 
 
Our finding that poorer physical health is associated with antidepressant use is also likely to 
reflect the complex relationship between psychological distress, chronic health conditions 
and disability. A previous study using data from the 45 and Up Study found that people with 
limitations to physical functioning such that they needed help for daily tasks were more likely 
to have high or very high levels of psychological distress compared to those who did not need 
help with daily tasks (Byles et al., 2014). Further, people with chronic health conditions such 
as diabetes and heart disease were also more likely to have high or very high levels of 
psychological distress (Byles et al., 2014).  
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While we found an association between antidepressant use and dispensings of antipsychotics, 
particularly low-dose antipsychotics, it is not possible to ascertain from the available data 
why there may be higher rates of antipsychotic dispensings among those who are 
antidepressant users.   
 
Further, the patterns of use of different antidepressant classes may reflect the tolerability 
profile of different antidepressants. While their efficacy is estimated to be similar, SSRIs are 
considered to have a more tolerable side-effect profile than older generation TCAs 
(Anderson, 2000). We found a higher proportion of TCA users were non-persistent users, 
although we cannot establish whether this was due to tolerability. People with indicators of 
mental illness (such as high psychological distress) were also more likely to be dispensed a 
combination of antidepressants during the study period then to be using a SSRI only, 
although we cannot ascertain from these data whether this was due to switching medication 
classes or being concurrently prescribed more than one class. Further, it has been previously 
found that the side-effect profiles of specific antidepressants are considered when a 
psychiatrist prescribes an antidepressant (Zimmerman et al., 2004); thus associations between 
classes of antidepressants and sociodemographic and health factors may reflect the differing 
importance of particular side-effects to different groups of people. 
 
CONCLUSIONS 
In our sample of mid-age concession card holders, we found clear patterns of antidepressant 
use which varied across sociodemographic, lifestyle and health-related factors. Females, 
those with lower levels of income or education, and those with poorer health profiles (low 
levels of physical activity, being overweight or obese, or being a current smoker or heavy 
alcohol drinker) were more likely to use antidepressants than their counterparts. Our findings 
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suggest, in addition to having poorer mental health, users of antidepressant medications are 
also sicker and are more likely to have impairments to physical functioning than people who 
do not use antidepressants.  
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Table 1: Sample characteristics by type of antidepressant user 
     Type of user 
 Total n  
 
 
 Non-user 
n (%) 
 
 Current 
n (%) 
 
 Past only 
n (%) 
 
 Non-persistent 
n (%) 
 
 p-value 
n=111,705  n=89,955 (81)  n=12,607 (11)  n=4,443 (4)  n=4,700 (4)   
Sex            
Male 49,747  42,337 (85)  4,146 (8)  1,579 (3)  1,685 (3)  p<.001 
Female 61,958  47,618 (77)  8,461 (14)  2,864 (5)  3,015 (5)   
Age group            
45-54 10,988  7,711 (70)  1,757 (16)  837 (8)  683 (6)  p<.001 
55-64 20,783  15,409 (74)  3,234 (16)  1,103 (5)  1,037 (5)   
65-74 43,648  36,462 (84)  4,261 (10)  1,380 (3)  1,545 (4)   
75-84 30,321  25,498 (84)  2,757 (9)  896 (3)  1,170 (4)   
85 or older 5,965  4,875 (82)  598 (10)  227 (4)  265 (4)   
Marriage status            
Married/defacto 73,466  60,825 (83)  7,360 (10)  2,510 (3)  2,771 (4)  p<.001 
Not married/defacto 37,485  28,539 (76)  5,155 (14)  1,895 (5)  1,896 (5)   
Country of birth            
Australia/New Zealand 84,020  67,167 (80)  10,041 (12)  3,446 (4)  3,366 (4)  p<.001 
Europe/North America 20,210  16,557 (82)  2,005 (10)  732 (4)  916 (5)   
Other 6,064  5,118 (84)  400 (7)  214 (4)  332 (5)   
Education            
No school cert 21,552  16,577 (77)  3,016 (14)  919 (4)  1,040 (5)  p<.001 
School cert 41,343  33,029 (80)  4,813 (12)  1,697 (4)  1,804 (4)   
Apprenticeship/diploma 33,576  27,717 (83)  3,347 (10)  1,224 (4)  1,288 (4)   
University degree 12,409  10,408 (84)  1,083 (9)  497 (4)  421 (3)   
Income            
<$20000 43,141  33,478 (78)  5,853 (14)  1,798 (4)  2,012 (5)  p<.001 
$20000-$39999 26,953  22,442(83)  2,584 (10)  959 (4)  968 (4)   
$40000-$69999 10,389  8,888 (86)  752  (7)  417 (4)  332 (3)   
>=$70000 2,202  1,918 (87)  98 (4)  108 (5)  78 (4)   
Private health insurance            
None 58,744   45,982 (78)  7,492 (13)  2,528 (4)  2,742 (5)  p<.001 
Private insurance 52,957  43,971 (83)  5,115 (10)  1,914 (4)  1,957 (4)   
Region of residence            
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     Type of user 
 Total n  
 
 
 Non-user 
n (%) 
 
 Current 
n (%) 
 
 Past only 
n (%) 
 
 Non-persistent 
n (%) 
 
 p-value 
Major cities 46,179  37,630 (81)  4,752 (10)  1,769 (4)  2,028 (4)  p<.001 
Inner Regional 41,435  33,024 (80)  4,972 (12)  1,710 (4)  1,729 (4)   
More remote 24,058  19,271 (80)  2,881 (12)  964 (4)  942 (4)   
BMI            
Underweight 1,691  1,326 (78)  197 (12)  64 (4)  104 (6)  p<.001 
Normal weight 36,050  29,843 (83)  3,353 (9)  1,329 (4)  1,525 (4)   
Overweight 39,506  32,384 (82)  4,041 (10)  1,505 (4)  1,576 (4)   
Obese 24,239  18,368 (76)  3,740 (15)  1,128 (5)  1,003 (4)   
Physical activity tertile            
Low 36,416  27,882 (77)  5,167 (14)  1,682 (5)  1,685 (5)  p<.001 
Moderate 37,196  30,489 (82)  3,816 (10)  1,351 (4)  1,540 (4)   
High 33,340  27,865 (84)  3,006 (9)  1,228 (4)  1,241 (4)   
Smoking status            
Never 60,018  49,208 (82)  6,092 (10)  2,275 (4)  2,443 (4)  p<.001 
Past 42,792  34,544 (81)  4,913 (11)  1,626 (4)  1,709 (4)   
Current 8,476  5,895 (70)  1,537 (18)  524 (6)  520 (6)   
Alcohol consumption            
None 46,022  35,676 (78)  6,191 (13)  2,037 (4)  2,118 (5)  p<.001 
Light 32,536  27,163 (83)  2,971 (9)  1,110 (3)  1,292 (4)   
Moderate 26,389  21,839 (83)  2,599 (10)  980 (4)  971 (4)   
Heavy 3,019  2,402 (80)  362 (12)  134 (4)  121 (4)   
Physical impairment            
None/minor 57,901  49,832 (86)  4,340 (8)  1,802 (3)  1,927 (3)  p<.001 
Moderate 15,773  12,153 (77)  2,145 (14)  714 (5)  761 (5)   
Severe 17,149  11,463 (67)  3,647 (21)  1,030 (6)  1,009 (6)   
Self-rated health            
Excellent/very good 41,396  36,268 (88)  2,760 (7)  1,117 (3)  1,251 (3)  p<.001 
Good 41,130  33,345 (81)  4,544 (11)  1,601 (4)  1,640 (4)   
Fair/poor 23,756  16,146 (68)  4,608 (19)  1,456 (6)  1,546 (7)   
Psychological distress            
Low 67,310  58,866 (87)  4,652 (7)  1,759 (3)  2,033 (3)  p<.001 
Moderate 14,491  10,072 (70)  25,88 (18)  950 (7)  881 (6)   
High/very high 9,034  4,680 (52)  27,52 (30)  885 (10)  717 (8)   
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     Type of user 
 Total n  
 
 
 Non-user 
n (%) 
 
 Current 
n (%) 
 
 Past only 
n (%) 
 
 Non-persistent 
n (%) 
 
 p-value 
Ever diagnosed with depression by a doctor           
No 80,777  71,706 (89)  4,276 (5)  1,946 (2)  2,849 (4)  p<.001 
Yes 15,519  5,758 (37)  6,670 (43)  1,873 (12)  1,218 (8)   
Current treatment for depression or anxiety           
No  100,066  87,458 (87)  5,915 (6)  2,988 (3)  3,705 (4)  p<.001 
Yes 11,639  2,497 (21)  6,692 (58)  1,455 (13)  995 (9)   
Use of antipsychotics            
Non-user 109,844  89,220 (81)  11,738 (11)  4,272 (4)  4,614 (4)  p<.001 
Low dose only 414  138 (33)  227 (55)  31 (7)  18 (4)   
Medium dose only 818  345 (42)  341 (42)  92 (11)  40 (5)   
High dose only 218  107 (49)  87 (40)  15 (7)  9 (4)   
Mixed dose 411  145 (35)  214 (52)  33 (8)  19 (5)   
Number of other medications dispensed           
<5 32,223  28,649 (89)  1,655 (5)  931 (3)  988 (3)  p<.001 
5 to 9 39,253  32,637 (83)  3,829 (10)  1,342 (3)  1,445 (4)   
10 or more 40,229  28,669 (71)  7,123 (18)  2,170 (5)  2,267 (6)   
Abbreviations: BMI=body mass index. Notes: Percentages are row percentages. Percentage missing: marriage status=1%; country of birth=1%; education=3%; income=26%; 
private health insurance=<1%; region of residence=<1%; BMI=9%; physical activity=4%; smoking status=<1%; alcohol consumption=3%; physical impairment=19%; self-
rated health=5%; psychological distress=19%; and ever diagnosed with depression by a doctor=14%. 
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Table 2: Numbers and percentage of antidepressant users by antidepressant class among those dispensed 
any antidepressant  
 SSRI-only  
n (%) 
 TCA-only 
n (%) 
 Other (single 
type) 
n (%) 
 Combination 
n (%) 
 Total n (%) 
Current 5,183 (41%)  3,535 (28%)  2,206 (18%)  1,683 (13%)  12,607 (100%) 
Past-only 1,883 (42%)  1,333 (30%)  696 (16%)  531 (12%)  4,443 (100%) 
Non-persistent 1,702 (36%)  2,097 (45%)  733 (16%)  168 (3%)  4,700 (100%) 
Total 8,768 (40%)  6,965 (32%)  3,635 (17%)  2,382 (11%)  21,750 (100%) 
Abbreviations: TCA=tricyclic antidepressants; and SSRI=selective serotonin reuptake inhibitors. Notes: other 
antidepressants include monoamine oxidase inhibitors and serotonin– noradrenaline reuptake inhibitors. 
Combination indicates that more than one class of antidepressants was dispensed to the same individual during 
the study period. 
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Table 3: Adjusted relative risk ratio for different types of antidepressants compared to using a SSRI only 
in relation to sociodemographic and health exposures, among current users only 
  TCA-only  Other (single type)  Combination 
  RRR (95% CI)^  RRR (95% CI)^  RRR (95% CI)^ 
Sex       
Male  1.00  1.00  1.00 
Female  1.34(1.21-1.48)  0.79(0.71-0.89)  1.10(0.97-1.25) 
Age group       
45-54  1.00  1.00  1.00 
55-64  1.30(1.09-1.54)  0.91(0.77-1.07)  0.74(0.62-0.88) 
65-74  1.92(1.63-2.26)  0.77(0.65-0.90)  0.69(0.58-0.82) 
75-84  2.95(2.48-3.50)  0.90(0.76-1.08)  0.81(0.66-0.98) 
85 or older  2.81(2.19-3.62)  0.96(0.71-1.28)  0.91(0.67-1.24) 
Country of birth       
Australia/New Zealand  1.00  1.00  1.00 
Europe/North America  0.89(0.79-1.02)  1.04(0.89-1.20)  1.22(1.04-1.43) 
Other  1.15(0.86-1.54)  1.29(0.95-1.75)  1.75(1.29-2.39) 
Marriage status       
Married/defacto  1.00  1.00  1.00 
Not married/defacto  1.05(0.96-1.16)  1.29(1.16-1.45)  1.17(1.04-1.32) 
Education       
No school cert  1.35(1.12-1.62)  1.00(0.82-1.23)  1.40(1.10-1.78) 
School cert  1.41(1.18-1.68)  1.09(0.90-1.32)  1.41(1.13-1.78) 
Apprenticeship/diploma  1.38(1.14-1.66)  1.17(0.96-1.43)  1.38(1.09-1.74) 
University degree  1.00  1.00  1.00 
Income       
<$20000  1.13(0.65-1.95)  0.86(0.48-1.53)  1.32(0.63-2.75) 
$20000-$39999  1.04(0.60-1.82)  0.79(0.44-1.42)  1.12(0.54-2.36) 
$40000-$69999  0.92(0.51-1.64)  0.93(0.51-1.72)  1.29(0.60-2.78) 
>=$70000  1.00  1.00  1.00 
Private health insurance       
None  1.00  1.00  1.00 
Private insurance  0.93(0.84-1.02)  1.07(0.96-1.19)  0.98(0.87-1.11) 
Region of residence       
Major cities  1.00  1.00  1.00 
Inner Regional  0.99(0.89-1.10)  1.01(0.89-1.14)  0.94(0.82-1.08) 
More remote  0.97(0.85-1.10)  0.92(0.80-1.07)  0.89(0.76-1.04) 
BMI       
Underweight  0.85(0.57-1.28)  1.21(0.78-1.86)  1.46(0.94-2.25) 
Normal weight  1.00  1.00  1.00 
Overweight  0.91(0.80-1.02)  0.93(0.81-1.07)  0.93(0.79-1.08) 
Obese  0.85(0.75-0.97)  0.97(0.84-1.11)  0.94(0.80-1.10) 
Physical activity tertile       
Low  1.05(0.93-1.19)  1.07(0.94-1.23)  1.16(1.00-1.35) 
Moderate  1.00(0.88-1.13)  0.98(0.85-1.13)  1.04(0.88-1.22) 
High  1.00  1.00  1.00 
Smoking status       
Never  1.00  1.00  1.00 
Past  0.97(0.88-1.08)  0.90(0.80-1.01)  1.01(0.88-1.15) 
Current  1.13(0.96-1.33)  1.54(1.30-1.82)  1.47(1.22-1.76) 
Alcohol consumption       
None  1.24(1.10-1.40)  1.22(1.06-1.40)  1.23(1.06-1.44) 
Light  1.12(0.97-1.28)  1.07(0.91-1.26)  0.99(0.83-1.19) 
Moderate  1.00  1.00  1.00 
Heavy  0.70(0.51-0.96)  1.10(0.81-1.50)  0.98(0.69-1.40) 
Physical impairment       
None/minor  1.00  1.00  1.00 
Moderate  1.18(1.02-1.35)  1.03(0.88-1.20)  1.33(1.11-1.58) 
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  TCA-only  Other (single type)  Combination 
  RRR (95% CI)^  RRR (95% CI)^  RRR (95% CI)^ 
Severe  1.43(1.27-1.61)  1.16(1.02-1.33)  1.78(1.54-2.07) 
Self-rated health       
Excellent/very good  1.00  1.00  1.00 
Good  1.18(1.05-1.34)  1.18(1.02-1.36)  1.45(1.22-1.72) 
Fair/poor  1.40(1.23-1.59)  1.33(1.15-1.53)  2.27(1.92-2.69) 
Psychological distress       
Low  1.00  1.00  1.00 
Moderate  0.68(0.60-0.77)  1.02(0.88-1.18)  1.19(1.01-1.42) 
High/very high  0.54(0.47-0.62)  1.42(1.23-1.64)  2.24(1.91-2.63) 
Ever diagnosed with 
depression by a doctor    
No  1.00  1.00  1.00 
Yes  0.24(0.22-0.27)  1.42(1.24-1.62)  1.45(1.25-1.68) 
Use of antipsychotics       
Non-user  1.00  1.00  1.00 
Low dose only  0.51(0.32-0.81)  2.86(2.05-3.99)  2.13(1.45-3.14) 
Medium dose only  0.78(0.56-1.10)  2.03(1.53-2.70)  2.06(1.52-2.81) 
High dose only  0.94(0.47-1.86)  2.14(1.18-3.89)  2.38(1.27-4.48) 
Mixed dose  0.64(0.38-1.09)  3.18(2.16-4.66)  4.35(2.98-6.36) 
Number of other medications dispensed 
<5  1.00  1.00  1.00 
5 to 9  1.68(1.42-1.98)  1.27(1.08-1.50)  1.81(1.44-2.26) 
10 or more  2.13(1.82-2.50)  1.37(1.17-1.61)  3.11(2.52-3.84) 
^Adjusted for sex, age, and country of birth. Abbreviations: RRR=relative risk ratio; CI=confidence intervals; 
TCA=tricyclic antidepressants; BMI=body mass index. Notes: The relative risk ratio of each class of 
antidepressant is calculated in reference to selective serotonin reuptake inhibitors users only.  
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Figure 1: Percentage of study participants using any antidepressant during the study period, according to 
age group and sex 
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Figure 2: Adjusted relative risk ratio for current antidepressant use compared to no use according to 
predisposing factors 
 
 
Notes: adjusted for age, sex and country of birth. Abbreviations: BMI=body mass index. RRR are on log scale.  
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Figure 3: Adjusted relative risk ratio for current antidepressant use compared to no use according to 
enabling factors 
 
 
Notes: adjusted for age, sex and country of birth. RRR are on log scale. 
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Figure 4: Adjusted relative risk ratio for current antidepressant use compared to no use according to 
need-related factors 
 
 
Notes: adjusted for age, sex and country of birth. RRR are on log scale. 
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Supplementary table 1: Adjusted relative risk ratio for antidepressant use across different user categories 
and according to sociodemographic and health exposures 
  Current  Past only  Non-persistent 
  RRR (95% CI)^  RRR (95% CI)^  RRR (95% CI)^ 
Sex       
Male  1.00  1.00  1.00 
Female  1.68(1.61-1.75)  1.46(1.37-1.56)  1.52(1.43-1.62) 
Age group       
45-54  1.00  1.00  1.00 
55-64  0.91(0.85-0.97)  0.66(0.60-0.72)  0.76(0.69-0.84) 
65-74  0.53(0.50-0.56)  0.36(0.33-0.39)  0.50(0.46-0.55) 
75-84  0.51(0.47-0.54)  0.34(0.31-0.38)  0.55(0.50-0.61) 
85 or older  0.53(0.48-0.59)  0.43(0.37-0.50)  0.60(0.52-0.70) 
Country of birth       
Australia/New Zealand  1.00  1.00  1.00 
Europe/North America  0.87(0.83-0.92)  0.94(0.87-1.03)  1.17(1.09-1.27) 
Other  0.49(0.44-0.54)  0.71(0.62-0.82)  1.21(1.07-1.36) 
Marriage status       
Married/defacto  1.00  1.00  1.00 
Not married/defacto  1.38(1.32-1.43)  1.47(1.38-1.57)  1.33(1.25-1.41) 
Education       
No school cert  1.60(1.49-1.73)  1.11(0.99-1.24)  1.52(1.35-1.71) 
School cert  1.22(1.14-1.31)  1.00(0.90-1.10)  1.29(1.16-1.44) 
Apprenticeship/diploma  1.14(1.06-1.23)  0.92(0.83-1.03)  1.20(1.07-1.34) 
University degree  1.00  1.00  1.00 
Income       
<$20000  3.51(2.85-4.32)  1.04(0.85-1.27)  1.48(1.17-1.87) 
$20000-$39999  2.30(1.86-2.83)  0.82(0.67-1.01)  1.09(0.86-1.38) 
$40000-$69999  1.67(1.34-2.08)  0.87(0.70-1.08)  0.94(0.73-1.20) 
>=$70000  1.00  1.00  1.00 
Private health insurance       
None  1.00  1.00  1.00 
Private insurance  0.76(0.73-0.79)  0.90(0.85-0.96)  0.82(0.77-0.87) 
Region of residence       
Major cities  1.00  1.00  1.00 
Inner Regional  1.06(1.02-1.11)  1.00(0.93-1.08)  0.97(0.91-1.04) 
More remote  1.01(0.96-1.06)  0.91(0.84-0.99)  0.89(0.82-0.96) 
BMI       
15-<18.5  1.22(1.04-1.42)  0.99(0.77-1.29)  1.42(1.15-1.74) 
18.5-<25  1.00  1.00  1.00 
25-<30  1.17(1.11-1.23)  1.10(1.02-1.19)  1.02(0.95-1.10) 
30-50  1.67(1.59-1.76)  1.26(1.16-1.37)  1.04(0.96-1.13) 
Physical activity tertile       
Low  1.75(1.66-1.83)  1.40(1.30-1.51)  1.35(1.25-1.46) 
Moderate  1.16(1.10-1.22)  1.03(0.95-1.12)  1.14(1.05-1.23) 
High  1.00  1.00  1.00 
Smoking status       
Never  1.00  1.00  1.00 
Past  1.32(1.27-1.38)  1.12(1.05-1.20)  1.12(1.05-1.19) 
Current  1.90(1.78-2.03)  1.49(1.34-1.65)  1.61(1.45-1.78) 
Alcohol consumption       
None  1.39(1.32-1.46)  1.19(1.10-1.29)  1.22(1.12-1.32) 
Light  0.99(0.94-1.05)  0.96(0.88-1.05)  1.11(1.02-1.21) 
Moderate  1.00  1.00  1.00 
Heavy  1.18(1.05-1.33)  1.10(0.91-1.33)  1.09(0.90-1.32) 
Physical impairment       
None/minor  1.00  1.00  1.00 
Moderate  2.10(1.98-2.22)  1.69(1.54-1.85)  1.63(1.49-1.78) 
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  Current  Past only  Non-persistent 
  RRR (95% CI)^  RRR (95% CI)^  RRR (95% CI)^ 
Severe  3.86(3.67-4.06)  2.59(2.39-2.81)  2.28(2.10-2.47) 
Self-rated health       
Excellent/very good  1.00  1.00  1.00 
Good  1.91(1.82-2.01)  1.63(1.51-1.76)  1.46(1.35-1.58) 
Fair/poor  4.04(3.83-4.25)  2.98(2.75-3.24)  2.80(2.59-3.02) 
Psychological distress       
Low  1.00  1.00  1.00 
Moderate  3.16(3.00-3.34)  2.88(2.65-3.13)  2.37(2.18-2.58) 
High/very high  7.22(6.81-7.66)  5.37(4.90-5.88)  3.93(3.58-4.32) 
Ever diagnosed with 
depression by a doctor   
 
 
 
 
No  1.00  1.00  1.00 
Yes  18.85(17.95-19.79)  10.61(9.89-11.39)  4.94(4.59-5.32) 
Use of antipsychotics       
Non-user  1.00  1.00  1.00 
Low dose only  12.26(9.85-15.27)  4.42(2.98-6.56)  2.37(1.45-3.88) 
Medium dose only  6.86(5.87-8.01)  4.39(3.46-5.57)  1.93(1.39-2.69) 
High dose only  6.05(4.50-8.13)  2.65(1.54-4.54)  1.51(0.76-3.00) 
Mixed dose  10.15(8.14-12.65)  3.83(2.60-5.65)  2.22(1.36-3.61) 
Number of other medications 
dispensed   
 
 
 
 
<5  1.00  1.00  1.00 
5 to 9  2.53(2.38-2.69)  1.63(1.50-1.78)  1.51(1.39-1.64) 
10 or more  5.97(5.62-6.34)  3.37(3.10-3.66)  2.86(2.64-3.09) 
^Adjusted for sex, age, and country of birth. Abbreviations: RRR=relative risk ratio; CI=confidence intervals; 
BMI=body mass index. Notes: The relative risk ratio of each user type is calculated in reference to non-users. 
 
 
 
